Invesco
SBBP

Invesco’s Strongbridge Biopharma plc. SBBP Stock Holding History

Invesco’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,895
Closed -$69K – 4088
2021
Q1 		$69K Buy
24,895
+1,836
+8% +$5.54K ﹤0.01% 3807
2020
Q4 		$56K Buy
+23,059
New +$55.6K ﹤0.01% 3734
2018
Q3 		– Sell
-15,780
Closed -$95K – 3941
2018
Q2 		$95K Sell
15,780
-24,401
-61% -$179K ﹤0.01% 3779
2018
Q1 		$356K Buy
+40,181
New +$301K ﹤0.01% 3452

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Invesco's SBBP Position: Q2 2021 in Review

Invesco sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 24,895 shares — an estimated $69K sold.

Invesco first reported a position in SBBP in Q1 2018 and held it in 4 quarters. The position peaked at $356K in Q1 2018. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Invesco reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 24,895 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $69K.
  • Invesco first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 4 quarters.
  • Invesco's Strongbridge Biopharma plc. position peaked at $356K in Q1 2018.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.